Two UNIL-CHUV projects win InnoTREK/FIT innovation grant

PACTT is happy to announce that in response to the 2020 spring call InnoTREK/FIT, two projects from UNIL-CHUV were awarded an innovation grant. These grants provide CHF 100’000.- financial support for the further development of an innovative project with a promising business potential in view of the creation of a start-up. The project Artemis is […]

PACTT is happy to announce that in response to the 2020 spring call InnoTREK/FIT, two projects from UNIL-CHUV were awarded an innovation grant.
These grants provide CHF 100’000.- financial support for the further development of an innovative project with a promising business potential in view of the creation of a start-up.

The project Artemis is developing an innovative, patented medical tool to meet a medical need in open surgical revascularization and vascular access. The biological mechanism leading to partial or total occlusion of blood vessels after surgical trauma is related to the development of intimal hyperplasia. Dr Laurent Vinet’s project aims to prevent restenosis of the vessels by releasing locally in a sustained manner drugs effective in the early and later phases of restenosis development, allowing a synergistic effect.
Dr Laurent Vinet will be hosted in Prof. Corpataux’s laboratory in the Cardiovascular Department at CHUV.

The project of Lars Backhaus named Intermedici is taking a completely new approach in digital medication. Intermedici’s products are based on the idea of MAGNA, a one-stop shop, AI-assisted online self-management database for different chronic diseases, in first line gout, rheumatoid arthritis and fibromyalgia. MAGNA will host disease specific data (clinical, patient reported, laboratory values, and wearables-derived) to document, analyze and improve patient care. The aim is to create clinically tested “digital drugs” for future prescriptions by doctors.

Mr Lars Backhaus will be hosted in Prof. Hugle’s laboratory in the Rheumatology Service at CHUV.

Table of Contents

Interested in this project? Let’s Talk

Get in touch to discuss licensing opportunities, collaborative research, or technical specifications.

Other news & events

Uncategorized
InnoTREK: one-year financial support to create your start-up

You are a UNIL-CHUV researcher who would like to create a start-up and need a financial support to start? Apply for a one-year InnoTREK grant of CHF 100’000.- to launch your project! Applications for the InnoTREK grant can be submitted throughout the year to the Knowledge Transfer UNIL CHUV. Project selection will take place in […]

Uncategorized
BioInnovation Day 2026 : Journée dédiée aux Innovateurs & Investisseurs

  Le BIND BioInnovation Day 2026 aura lieu le 1er avril 2026 au CHUV – Auditoire César Roux. Une trentaine de projets innovants issus des meilleures institutions académiques et de recherche de Suisse occidentale y seront présentés devant le public et les investisseurs. L’événement est organisé par BioAlps en partenariat avec KT UNIL–CHUV et UNITEC. […]

Uncategorized
A Unil Discovery for Vaccine Development Turns into a Start-Up

The CRISPRi-seq technology, stemming from fundamental research within the team of Professor Jan-Willem Veening at the University of Lausanne, has reached a decisive milestone: it has been licensed to the start-up “i-Seq Biotechnology”. This innovation paves the way for new vaccines against diseases for which there is currently no protection. It all started with a […]

What is your situation ?

Our team is available to discuss your needs, for free.

For Researcher

A personalized service to inventors
In collaboration with a professional network, with regards to all aspects of technology evaluation, protection of intellectual property rights and creation of a start-up.

For Industry

Find a collaboration, or invest in a technology
We are the primary contact point to engage in any collaboration, partnership or venture with researchers from the University of Lausanne or the CHUV.